Massachusetts updates to MCSR & SLN data validation
What Changed
In late 2023, Massachusetts began transitioning their license data to a new platform to publish professional license (MA SLN) and all Massachusetts Controlled Substance Registration (MCSR) information. This changed data availability, creating complexity around data acquisition and storage and highlighted Massachusetts regulations around prescription drugs.
In Massachusetts all prescription drugs are considered a “controlled substance”. A MCSR is required in addition to the professional license (MA SLN) to prescribe, request/receive prescription drug samples, or receive trade prescription drug products. The MCSR is location specific, and an individual licensee may hold multiple MCSRs.
What to be Aware of
Since early December 2023, MedPro Systems has been communicating directly with the Massachusetts MCSR and IT departments regarding data required for verification, evaluated the information published by the state, and worked with them to identify anomalies and gaps in the data, which were then remedied.
These changes have introduced an address-specific component to the license verification process – requiring the standard SLN verification but adding new checks around valid MCSR licenses for each practitioner.
How MedPro is Providing Guidance to Our Customers
MedPro met with the Massachusetts Program Counsel Department of Public Health – Drug Control Program to understand how the industry can comply with Massachusetts regulations to provide prescription drug products if the address is redacted, and has received valuable guidance from Massachusetts to assist our customers in this effort.
To ensure our customers remain compliant alongside these changes, MedPro is associating MA SLN to MCSR data for validation fulfillment, along with providing data quality checks, proactive monitoring, and ongoing data delivery and support.
As these changes evolve, MedPro will continue to evaluate the MA SLN and MCSR data for our customers who require Massachusetts prescribers’ practice and MSCR licenses for their compliance and business objectives.
Additional Resources
- View the press release
- Watch the webinar
- Download the one page guide
- See FAQs